Skip to main content
Caplight Logo









First Ascent Biomedical

First Ascent Biomedical

Private
Miami, FloridaHealthcare & Life Scienceshttps://firstascentbiomedical.com/

Last Round

Grant

Mar 3, 2025

Total Funding Raised

$4M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

First Ascent Biomedical is a biotechnology company that provides a drug prediction platform designed to deliver personalized cancer treatment planning for patients.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Healthcare Analytics, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

precision oncologyclinical decision supportfunctional drug sensitivitycancer diagnosticsdrug sensitivity screeninggenomic sequencingcancer treatment planningpersonalized medicineAI in oncologytumor profilingbiomarker discoverypatient stratificationlive-cell testingCLIA certified labpredictive oncology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

First Ascent Biomedical Comparables

Compare First Ascent Biomedical with similar companies based on industry and business-model similarity.

First Ascent Biomedical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Travera
87%
SageMedic Corp.
84%
Xilis
80%

First Ascent Biomedical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 3, 2025
GrantFeb 28, 2025
VC RoundJan 13, 2025

Key People

Founding team and executive leadership

Noah Berlow

Chief Technology Officer

Executive Team

Dylan Anderson

CFO - Fractional

Executive Team

Izack Bailey

Chief Financial Officer

Executive Team

First Ascent Biomedical Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Grew 18% QoQ, from 17 to 20 employees.

  • Jul 22, 2025

    Attended the 2025 CancerX Accelerator Showcase in Boston.

First Ascent Biomedical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

First Ascent Biomedical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about First Ascent Biomedical's valuation, stock price, and market status.

Firmographic Details

HeadquartersMiami, Florida
Employee Range20
Year Founded2018
Last FundingMar 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?